
About FibroHeal
FibroHeal is a Healthcare company based in Bengaluru (India) founded in 2017 by Subramanian Shivaraman, Vivek Mishra, and Bharat Tandon. FibroHeal has raised $3.8 million across 9 funding rounds from investors including C-CAMP, Startup Karnataka and KITVEN. The company has 62 employees. FibroHeal was last valued at $7.05 million in November 2022. Its chief executive, as recorded, is Vivek Mishra. Its Indian entity Fibroheal Woundcare Private Limited reported revenue of βΉ5.37 Cr. FibroHeal offers products and services including D-Fibroheal Scarlite, D-Fibroheal Ag Particle, D-Fibroheal Particle, Fibrovid, and FibroZyme. Its focus areas include Life Sciences, Regenerative Medicine, Biomaterials and Dressing.
Company details
Developer of silk proteins as biomaterials for wound healing. The company is leveraging the biomaterial application of silk proteins to develop the most innovative advance and active wound care products to heal acute and chronic wounds. The company is working exclusively on healing different types of acute and chronic wounds and has a comprehensive product range addressing different stages of wounds.
- Headquarters Bengaluru, India
- Employees 62
- Founders Subramanian Shivaraman, Vivek Mishra, Bharat Tandon
- Stage Minicorn
- SectorsHealthcare
- Emailβ’β’β’β’β’β’β’β’
- Phoneβ’β’β’β’ β’β’β’β’
- Website fibroheal.com
- Social LinkedIn X Facebook Instagram
- Legal Name Fibroheal Woundcare Private Limited
- Date of Incorporation 06 Apr, 2017
- Jurisdiction Doddaballapura, Karnataka, India
- Annual Revenue₹5.37 Cr
FY 2026 · +3% YoY
- Net Loss-₹4.97 Cr
FY 2026 · -96% margin
- EBITDA-₹3.41 Cr
FY 2026 · -66% margin
- Total Equity Funding$3.8M (USD)
in 9 rounds
- Latest Funding Round$1.47M (USD), Angel Round
Jul 2026
- InvestorsC-CAMP
& 9 more
- Employee Count62
Associated legal entities of FibroHeal
FibroHeal operates through Fibroheal Woundcare Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2026) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Fibroheal Woundcare Private Limited CIN U74999KA2017PTC101983 | Active | 06 Apr 2017 | Doddaballapura, Karnataka | ₹5.4 Cr | 29 | 2 | View details |
Products & Services of FibroHeal
FibroHeal offers a comprehensive portfolio of products and services, including D-Fibroheal Scarlite, D-Fibroheal Ag Particle, D-Fibroheal Particle, Fibrovid, and FibroZyme.
Product for effective scar management in wound healing.
Antimicrobial solution for controlling wound infections.
Material for general wound care and healing support.
Aid for viral or general skin wound treatment.
Enzyme-based product for tissue debridement in wounds.
Cream to maintain moisture in wound care routines.
Adhesive foam for protective wound coverage.
Foam with antimicrobial properties for wounds.
Adhesive antimicrobial foam for wound protection.
Gel to provide hydration for wound healing.
Spray for applying moisture to wounds.
General product for aiding wound recovery.
Meshed material for wound coverage and healing.
Polyurethane foam for non-adhesive wound protection.
Antimicrobial version for infection prevention.
Funding Insights of FibroHeal
FibroHeal has successfully raised a total of $3.8M across 9 strategic funding rounds. The most recent funding activity was a Angel Round of $1.47 million completed in July 2026. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $3.8M
- Total Rounds 9
- Last Round Angel Round β $1.47M
- First Round $141,834
(Dec 2018)
- Investors Count 10
All 9 funding rounds of FibroHeal with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul 2026 | $1.47M | Angel Round | β | β | β |
| Dec 2024 | $742,417 | Seed | β | β | |
| Nov 2022 | $552,479 | Seed | $7.05M | KITVEN | |
| Mar 2022 | $1M | Debt – Venture | β | β | |
| Apr 2021 | $597,335 | Seed | $5.76M | Karnataka Trustee | |
| Mar 2020 | $99,233 | Seed | $β’β’β’β’β’ | C-CAMP | β |
| Nov 2019 | $195,017 | Angel Round | $β’β’β’β’β’ | Tejas Subramanian | |
| Aug 2019 | Grant | β | β | ||
| Dec 2018 | $141,834 | Angel Round | $β’β’β’β’β’ | Tejas Subramanian |
| Date | Valuation | Stage |
|---|---|---|
| Nov 2022 | $7.05M | β’β’β’β’β’β’β’β’ |
| Apr 2021 | $5.76M | β’β’β’β’β’β’β’β’ |
| Mar 2020 | $β’β’β’β’β’ | β’β’β’β’β’β’β’β’ |
Full valuation and stage history of FibroHeal
Every valuation point, the growth-stage changes (minicorn, soonicorn, unicorn) and the dates behind them require an active premium plan.
- All valuation points
- Stage changes
- Dates
- Exports
Verified entity values are shown only after access is granted.
Last known valuation $7.05M (Nov 2022). 10 investors in total: 6 institutional and 4 angel.
Investors in FibroHeal
FibroHeal has secured backing from 10 investors, including angel, venture fund, and institutional investors. Prominent investors backing the company include C-CAMP, Startup Karnataka and KITVEN.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Venture capital fund backed by government financial institutions focused on early and growth stage startups | 1999 | kitven.in | Bengaluru, India | |
Venture capital is provided to biotech and health-tech startups. | Bengaluru, India | |||
Business incubation services are provided across multiple sectors. | birac.nic.in | Delhi, India | ||
Bioscience research, innovation, and entrepreneurship facilitation in life sciences are conducted in India. | 2010 | ccamp.res.in | Bengaluru, India | |
Venture capital firm focused on multiple sectors | Bengaluru, India | |||
Support for startups in Karnataka is delivered through policies, funding, and networking services. | 2004 | missionstartupkarnataka.org | Bengaluru, India | |
KN KK Narayanan | unknown_c693a7345a494cd1a | |||
TS Tejas Subramanian | unknown_9ac375d27625493aa | |||
BT Bharat Tandon | Angel investor and entrepreneur, focused on tech startups in India. | unknown_2de529d6fd0946c7b | ||
VM Vivek Mishra | Angel investor and entrepreneur, focusing on tech startups in India. | unknown_2009af98df704c26a |
Investor details for FibroHeal
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Fibroheal Woundcare Private Limited (FibroHeal)
Fibroheal Woundcare Private Limited is the primary company behind FibroHeal. The board of Fibroheal Woundcare Private Limited currently have 2 directors; the longest-serving is Vivek Mishra, appointed in 2017. 1 earlier director has ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Vivek Mishra DIN 07616402 | Director | 06 Apr 2017 | 9 yrs 7 mo | Fibroheal Woundcare Private Limited |
| Bharat Tandon DIN 00832149 | Director | 06 Apr 2017 | 9 yrs 7 mo | Fibroheal Woundcare Private Limited |
People of FibroHeal
3 people are tracked at FibroHeal (3 in leadership); the tracked headcount is 62.
| Name | Role | Group |
|---|---|---|
| Co-Founder & Director | Leadership | |
| Co-Founder & CEO | Leadership | |
| Co-Founder & Director | Leadership |
Complete people profiles for FibroHeal
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of FibroHeal
Figures of Fibroheal Woundcare Private Limited, the primary company behind FibroHeal, for FY 2026. Revenue was ₹5.37 Cr (+3% year on year). Net loss was -₹4.97 Cr (-96% margin). EBITDA was -₹3.41 Cr (-66% margin). Revenue has grown at a compounded annual rate of +33% over three years and +79% over five years.
- ₹5.37 CrRevenue · FY 2026 · +3% YoY
- -₹4.97 CrNet loss · -96% margin
- -₹3.41 CrEBITDA · -66% margin
- ₹1.70 CrPaid-up capital
- 29Employees (provident fund records)
- +33%Revenue CAGR, 3 years
- +79%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Fibroheal Woundcare Private Limited are on its company page.
Detailed financial statements for FibroHeal
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of FibroHeal
4 dated milestones of FibroHeal across 9 years, from founding to its latest funding, stage changes and deals.
- Founded FibroHeal is founded.
- Funding First funding round of $142K.
- Milestone Reaches Minicorn status.
- Funding Latest funding round, Angel Round, of $1.5M.
Web traffic of FibroHeal
The website of FibroHeal (fibroheal.com) receives about 3.6K visits a month.
- Monthly visits3.6K
▼ 45.9% vs previous month
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Fibroheal
Complete news archive for FibroHeal
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about FibroHeal
FibroHeal was founded in 2017 and raised its 1st funding round 1 year after it was founded.
FibroHeal is headquartered in Bengaluru, India. It is registered at Bengaluru, Karnataka, India.
Vivek Mishra is the CEO of FibroHeal, as recorded in our data. They have also founded this company.
FibroHeal is a funded company, having raised a total of $3.8M across 9 funding rounds to date. The company's 1st funding round was a Angel Round of $141.83K, raised on Dec 2018.
FibroHeal has 62 employees.
The primary company behind FibroHeal, Fibroheal Woundcare Private Limited, reported revenue of βΉ5.37 Cr for FY 2026, up 3% year on year.
Developer of silk proteins as biomaterials for wound healing. The company is leveraging the biomaterial application of silk proteins to develop the most innovative advance and active wound care products to heal acute and chronic wounds. The company is working exclusively on healing different types of acute and chronic wounds and has a comprehensive product range addressing different stages of wounds.
FibroHeal offers D-Fibroheal Scarlite, D-Fibroheal Ag Particle, D-Fibroheal Particle, Fibrovid, and 6 more products and services.
FibroHeal has 10 investors. Key investors include C-CAMP, Startup Karnataka, KITVEN, KK Narayanan, and Karnataka Trustee.
The valuation of FibroHeal is $7.05M as of Nov 2022.
FibroHeal operates through Fibroheal Woundcare Private Limited.
The legal entities of FibroHeal currently have 2 directors, including Vivek Mishra, Bharat Tandon.
